CLPT vs PROF: stock comparison and AI forecast
Clearpoint Neuro, Inc. (CLPT) and Profound Medical Corp. (PROF) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CLPT Clearpoint Neuro, Inc.
- Market Cap
- $276M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
PROF Profound Medical Corp.
- Price
- $7.21 +0.7% · 6M
- Market Cap
- $263M
- P/E Ratio
- 7.7x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CLPT and PROF have similar market capitalizations ($276M and $263M).
- CLPT carries 3.13 times debt per unit of equity, against 0.37 times for PROF.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CLPT | PROF |
|---|---|---|
| Market Cap | $276M | $263M |
| P/E Ratio | – | 7.67x |
| P/B Ratio | 10.11x | 6.20x |
| EPS | $-0.93 | $0.94 |
| Book Value/Share | $0.85 | $1.16 |
| Revenue/Share | $1.42 | $0.65 |
| FCF/Share | $-1.04 | – |
Profitability & Margins
| Metric | CLPT | PROF |
|---|---|---|
| ROE | -132.5% | – |
| ROA | -32.1% | – |
| ROIC | -31.2% | -74.4% |
| Gross Margin | 61.4% | 73.9% |
| Operating Margin | -70.6% | -145.1% |
| Net Margin | -79.4% | – |
| EBT Margin | -79.5% | -137.1% |
| Tax Rate | 0.1% | -0.3% |
Financial Health
| Metric | CLPT | PROF |
|---|---|---|
| Current Ratio | 6.76x | 4.54x |
| Quick Ratio | 5.77x | 3.70x |
| D/E Ratio | 3.13x | 0.37x |
| Financial Leverage | 4.13x | 1.37x |
| Interest Coverage | -11.6x | -97.8x |
| Working Capital | $57M | $43M |
Cash Flow
| Metric | CLPT | PROF |
|---|---|---|
| Operating Cash Flow | -$32M | -$31M |
| Free Cash Flow | -$33M | – |
| Capital Spending | -$1M | – |
| FCF/Sales | -73.0% | – |
| CapEx/Sales | 2.3% | – |
Operational Efficiency
| Metric | CLPT | PROF |
|---|---|---|
| Asset Turnover | 0.40x | 0.41x |
| Receivables Turnover | 5.7x | – |
| Inventory Turnover | 1.8x | 0.6x |
| Fixed Assets Turnover | 14.6x | 55.0x |
| Days Sales Outstanding | 64 days | – |
| Days Inventory | 203 days | 605 days |
| Payables Period | 22 days | 62 days |
| Cash Conversion Cycle | 245 days | – |
Income Statement
| Metric | CLPT | PROF |
|---|---|---|
| Total Revenue | $45M | $24M |
| Operating Income | -$32M | -$34M |
| Net Income | -$36M | – |
| R&D Expense | $16M | $21M |
| SG&A Expense | $20M | $31M |
| Cost of Goods Sold | $18M | $6M |
Dividend & Shareholder Information
| Metric | CLPT | PROF |
|---|---|---|
| Shares Outstanding | 32M | 37M |
| EPS Growth | – | 74.1% |
CLPT vs PROF: stock comparison and AI forecast
Which is bigger, CLPT or PROF?
CLPT and PROF have similar market capitalizations ($276M and $263M).
Which one does Intratio's AI model rank higher, CLPT or PROF?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.